Not medical advice. Talk to your provider before using any peptide. Full disclaimer
Peptide Schedule Research TeamReviewed Apr 7, 202622 Citations
Tesamorelin Dosage Calculator
Growth Hormone · FDA Approved · Grade A · 8-11 min half-life · Injection
Calculate your dose
Adjust vial, water and dose. The answer updates live.
All three take the same units for the same dose. A smaller barrel just spreads it over more space.
on a U-100 syringe for a 1,400 mcg = 1.4 mg dose
Check that your syringe says U-100.
Mix your 2 mg vial with 0.5 mL of the diluent its directions name. Draw to 35.0 units on a U-100 syringe for a 1.4 mg dose. This vial will last 1 dose.
A reminder for 1.4 mg (35 units) every day, with a free account.
Dose math and a schedule you can keep.
Syringe units in one tap. A free account adds dose reminders and calendar sync, plus alerts on the peptides you save.
Track every dose with reminders and a calendar.
- Dose remindersPush or calendar alarm
- Peptide alertsFor peptides you save
- Calendar syncApple, Google, Outlook
- Supply countsDoses left per vial
Your plans, logs and saved peptides sync to every device.
Opens a preview of your schedule first.Opens the builder with this mix. Save it to your protocols.
Your logs and saved lists are never sold, and not shared except where you choose.
Dose math and a schedule you can keep.
A reminder before each dose, calendar sync and doses left per vial, with a free account.
Opens a preview of your schedule first.Opens the builder with this mix. Save it to your protocols.
What you need to mix this6 items, matched to your vial, diluent and syringe
- Tesamorelin, 2 mg vialThe vial size set in the calculator.
- Diluent, 0.5 mLEGRIFTA SV: only the Sterile Water for Injection in its kit, not bacteriostatic water. EGRIFTA WR and compounded vials: the diluent their directions or pharmacy name.
- 1 mL U-100 insulin syringe (100 units)Matches the syringe set in the calculator. Use a new sterile one for every injection.
- Alcohol swabsFor each vial stopper every time a needle goes in, and for the injection site. Let the alcohol dry first.
- A sharps containerUsed syringes go in right after each injection, never loose in the trash.
- Storage after mixingEGRIFTA SV: inject right after mixing and discard any unused solution; do not refrigerate or freeze it. EGRIFTA WR: keep the mixed vial at 20-25°C and discard it 7 days after mixing. Compounded vials: refrigerate at 2-8°C, use within 14 days.
How to choose each item: the peptide supplies guide.
About Tesamorelin
Turns your vial size, diluent, and dose into exact syringe units. Free to use.
Tesamorelin is the only FDA-approved GHRH analog for visceral fat reduction, backed by Phase 3 data in 816 patients. Originally indicated for HIV lipodystrophy, it's now widely used off-label for belly fat and GH optimization. The catch is that visceral fat returned within six months of stopping in the trials.
View side effects and safety warnings →
Quick-Start: Reconstitution
- 1Gather your supplies. You'll need a 2 mg tesamorelin vial (lyophilized powder), 0.5 mL of diluent, a mixing syringe with an 18-gauge needle for reconstitution, and a U-100 insulin syringe (29 to 31 gauge, half-inch needle) for injection. EGRIFTA SV comes with its own diluent, and its label says to use only that one. Do not use bacteriostatic water with EGRIFTA SV. For a compounded vial, use the diluent your pharmacy names.
- 2Reconstitute the vial. Draw 0.5 mL of diluent into the mixing syringe. Inject slowly down the inside wall of the vial. Do not shake; roll the vial gently between your hands until the powder dissolves. This gives you 4 mg/mL. The solution should be clear and colorless; discard if cloudy or discolored.
- 3Draw your dose. Using a fresh U-100 insulin syringe, draw 35 units (0.35 mL) for the 1.4 mg EGRIFTA SV label dose. The 2 mg Phase 3 trial dose most community protocols use is 50 units (0.5 mL, the whole vial).
Tesamorelin Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 1.4 mg | Daily |
| Moderate | 1.4 mg | Daily |
| Aggressive | 1.4 mg | Daily |
With a 5 mg vial and 2 mL bacteriostatic water, you get 2.5 mg/mL (2500 mcg/mL). At that concentration: 2000 mcg (the 2 mg Phase 3 trial dose most community protocols use) is 80 units on a U-100 insulin syringe. That's 0.8 mL, so you'll use close to half the syringe. Each 5 mg vial gives you 2.5 daily doses at 2 mg per day. The EGRIFTA SV label dose is lower: 1.4 mg (0.35 mL of its own reconstituted 2 mg vial) once daily.
With the 2 mg vial (EGRIFTA SV) and 0.5 mL of diluent, you get 4 mg/mL: 1.4 mg is 35 units (0.35 mL), and a 2 mg dose is the whole vial, 50 units (0.5 mL). Each 2 mg vial makes one dose.
Inject into abdominal subcutaneous fat only. The FDA label specifies this, and the clinical data was collected this way. Don't rotate to thigh or arm. Rotate within the abdomen, at least 2 cm from the umbilicus.
The non-obvious thing: your IGF-1 check at four to six weeks isn't optional. If IGF-1 hasn't risen, either the peptide is degraded, your injection technique is off, or you've drawn a bad batch from the compounder. Don't run a full 26-week cycle without confirming the molecule is actually working.
Pre-bed injection is the community preference for off-label use because it matches the natural nocturnal GH surge. FDA trials used morning dosing. Either works; consistency matters more than timing.
Dosing based on EGRIFTA SV (tesamorelin) FDA Prescribing Information (2026): 1.4 mg once daily: 22 published references.View all sources →
How the Tesamorelin Math Works
- 2mg in 0.5mL
- =4mg/mL
- 4mg/mL
- =40 mcg per unit
- 1,400 mcg / 40
- =35 units
- 2mg / 1,400 mcg
- =1 dose
Based on a 2mg vial, 0.5mL of the diluent its directions name, the beginner dose (1,400 mcg), and a U-100 syringe. Change any input in the calculator and every line moves with it.
Ask AI about this math
Cross-check your Tesamorelin reconstitution math with AI
Tesamorelin Cost
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Tesamorelin Pharmacokinetics
Pharmacokinetics: Active Dose Over Time
t½ = 8-11 min (single SC dose, EGRIFTA SV and WR labels)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Comparing Options?
Related Tools
Frequently Asked Questions
How popular is Tesamorelin?
Popular. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
110 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Moderate search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.